公开(公告)号：US20100305139A1

公开(公告)日：2010-12-02

申请号：US12854538

申请日：2010-08-11

Applicant: Yuji ABE ,  Aki KUSUNOKI ,  Yoshiharu HAYASHI ,  Fumihiko AKAHOSHI

Inventor： Yuji ABE ,  Aki KUSUNOKI ,  Yoshiharu HAYASHI ,  Fumihiko AKAHOSHI

IPC: A61K31/496 ,  A61P3/00

CPC classification number: A61K31/496 ,  C07D417/14

Abstract: The present invention provides a pharmaceutical agent for the treatment and/or prophylaxis of abnormal blood glucose and lipid metabolism associated with eating, for which a sufficient treatment method or a therapeutic drug has not been found.

Abstract translation: 本发明提供了用于治疗和/或预防与进食相关的异常血糖和脂质代谢的药剂，其中尚未发现足够的治疗方法或治疗药物。

公开(公告)号：US20090088442A1

公开(公告)日：2009-04-02

申请号：US11912717

申请日：2006-04-26

Applicant: Yuji Abe ,  Aki Kusunoki ,  Yoshiharu Hayashi ,  Fumihiko Akahoshi

Inventor： Yuji Abe ,  Aki Kusunoki ,  Yoshiharu Hayashi ,  Fumihiko Akahoshi

IPC: A61K31/496 ,  C07D413/14 ,  A61P3/08 ,  A61P3/06

CPC classification number: A61K31/496 ,  C07D417/14

Abstract: The present invention provides a pharmaceutical agent for the treatment and/or prophylaxis of abnormal blood glucose and lipid metabolism associated with eating, for which a sufficient treatment method or a therapeutic drug has not been found.

Abstract translation: 本发明提供了用于治疗和/或预防与进食相关的异常血糖和脂质代谢的药剂，其中尚未发现足够的治疗方法或治疗药物。